Stock Snapshot
Price Performance
Recommendation Rationale
Basis of our Recommendation
Why We Like This Stock
Things To Watch Out For
Key Parameters
Financial Snapshot
| Actuals | Forecast | ||||
|---|---|---|---|---|---|
| FY24 | FY25 | FY26 | FY27 | FY28 | |
| Revenue (Cr.) | 819 | 922 | 811 | 891 | 978 |
| Profit Before Tax (Cr.) | 92 | 96 | 28 | 38 | 40 |
| PBT Margin | 11.3% | 10.4% | 3.4% | 4.3% | 4.1% |
| Net Profit (Cr.) | 89 | 100 | 28 | 29 | 30 |
| EPS | 17.5 | 19.7 | 5.5 | 5.6 | 5.9 |
Company Overview
Show Company Profile
Orchid Pharma Limited, a pharmaceutical company, engages in the development, manufacture, and marketing of active pharmaceutical ingredients, bulk actives, finished dosage formulations, and nutraceuticals in India. Its active pharmaceutical ingredients product portfolio includes oral cephalosporins, injectable cephalosporins; human and veterinary products; and antibiotics, including betalactam, macrolide, fluoroquinolone, and imidazole. The company also exports its products to approximately 40 countries internationally. The company was formerly known as Orchid Chemicals & Pharmaceuticals Limited and changed its name to Orchid Pharma Limited in October 2015. Orchid Pharma Limited was incorporated in 1992 and is headquartered in Chennai, India. Orchid Pharma Limited operates as a subsidiary of Dhanuka Laboratories Limited.